Salem Erode Inv.

Who are in the management team of Salem Erode Inv.?

The management team of Salem Erode Inv. includes K G Anilkumar (Managing Director), Umadevi Anil Kumar (Director), Seseendran Veliyath, T G Babu, and Ambadath Aiyyappan Balan (Independent Directors), along with Manisha Nandakumar Menon (Company Secretary & Compliance Officer).

The management team of Salem Erode Inv. includes the following individuals:<BR><BR>1. K G Anilkumar - Managing Director<BR>2. Umadevi Anil Kumar - Director<BR>3. Seseendran Veliyath - Independent Director<BR>4. T G Babu - Independent Director<BR>5. Manisha Nandakumar Menon - Company Secretary & Compliance Officer<BR>6. Ambadath Aiyyappan Balan - Independent Director<BR><BR>If you need further details about any specific member or their roles, feel free to ask!

What does Salem Erode Inv. do?

Salem Erode Investments Ltd is a Non Banking Financial Company (NBFC) focused on the micro-cap market, with recent net sales of 1 Cr and a net profit of -1 Cr as of June 2026. The company has a market cap of INR 42 Cr and operates from Chennai, Tamil Nadu.

Overview:<BR>Salem Erode Investments Ltd operates as a Non Banking Financial Company (NBFC) within the micro-cap market segment.<BR><BR>History:<BR>The company was originally incorporated as Salem Erode Electricity Distribution Limited in 1931. It underwent several name changes, becoming Salem Erode Tea & Investment Co. Limited in 1975 and finally Salem Erode Investments Limited in 1992. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: -1 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 42 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.95 <BR>Return on Equity: -35.56% <BR>Price to Book: 2.65<BR><BR>Contact Details:<BR>Address: Do No 61/A8(38/A8) VJP Parijat, Apart 1 st Aven Ashok Nagar Chennai Tamil Nadu : 600083 <BR>Tel: 91-33-9497801053 <BR>Email: salemerodeinvestmentsltd@gmail.com <BR>Website: http://www.salemerode.com

Who are the peers of the Salem Erode Inv.?

Salem Erode Inv.'s peers include ARC Finance, Relic Tech., Sugal & Damani, and others. It has below-average growth and a 1-year return of -6.08%, higher than Toyam Sports but lower than Prism Medico, which leads with a 68.10% return.

Peers: The peers of Salem Erode Inv. are ARC Finance, Relic Tech., Sugal & Damani, Prism Medico, MSL Global, AD Manum Finance, Amrapali Fincap, HB Stockholdings, Toyam Sports.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sugal & Damani, MSL Global, AD Manum Finance, and the rest. Average management risk is found at Toyam Sports, while Below Average management risk is noted at ARC Finance, Salem Erode Inv., Relic Tech., Prism Medico, Amrapali Fincap, HB Stockholdings. Growth is Excellent at Sugal & Damani, MSL Global, while Good growth is seen at ARC Finance, AD Manum Finance, and the rest. Below Average growth is present at Salem Erode Inv., Relic Tech., Prism Medico, Amrapali Fincap, HB Stockholdings, Toyam Sports.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Prism Medico at 68.10%, while Toyam Sports has the lowest at -40.57%. Salem Erode Inv.'s 1-year return is -6.08%, which is higher than Toyam Sports but lower than Prism Medico. Additionally, MSL Global, Amrapali Fincap, HB Stockholdings, and Toyam Sports have negative six-month returns.

How big is Salem Erode Inv.?

As of 31st August, Salem Erode Investments Ltd has a market capitalization of 42.00 Cr and reported Net Sales of 3.31 Cr with a Net Profit loss of 5.17 Cr for the latest four quarters.

As of 31st August, Salem Erode Investments Ltd has a market capitalization of 42.00 Cr, categorizing it as a Micro Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 3.31 Cr. However, it experienced a loss of 5.17 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2018, where Shareholder's Funds amounted to 17.06 Cr and Total Assets were recorded at 17.76 Cr.

Which are the latest news on Salem Erode Inv.?

Should I buy, sell or hold Salem Erode Investments Ltd?

Are Salem Erode Investments Ltd latest results good or bad?

Salem Erode Investments Ltd's latest results are concerning, showing a net loss of ₹1.40 crore in Q4 FY26, a 15.70% increase in losses, and a significant decline in revenue. With deep operational issues and seven consecutive quarters of losses, the outlook is bleak, and it is recommended to consider exiting any positions in the stock.

The latest results for Salem Erode Investments Ltd are quite concerning. In Q4 FY26, the company reported a net loss of ₹1.40 crore, which is a 15.70% increase in losses compared to the previous quarter. Revenue also declined significantly, dropping 13.41% quarter-on-quarter to ₹0.71 crore, and 20.22% year-on-year.<BR><BR>The operating margin is deeply negative at -104.23%, indicating severe operational issues. Additionally, the return on equity stands at -27.09%, reflecting substantial value destruction for shareholders. The company's financial distress is evident, with seven consecutive quarters of losses and a troubling cost structure where employee costs exceed total revenue by 39.44%.<BR><BR>Overall, the financial metrics suggest that the company is facing significant challenges, and the investment outlook appears bleak. The recommendation is to consider exiting any positions in the stock, as it is classified as a "Strong Sell."

When is the next results date for Salem Erode Investments Ltd?

The next results date for Salem Erode Investments Ltd is 26 May 2026.

The next results date for Salem Erode Investments Ltd is scheduled for 26 May 2026.

Is Salem Erode Inv. overvalued or undervalued?

As of December 4, 2025, Salem Erode Investment is considered overvalued with a negative PE ratio of -9.99 and an EV to EBITDA of -27.99, significantly worse than peers like Bajaj Finance and Life Insurance, and has underperformed with a year-to-date return of -21.69% compared to the Sensex's 9.12%.

As of 4 December 2025, the valuation grade for Salem Erode Investment has moved from risky to expensive, indicating a shift in perception regarding its value. The company is currently overvalued, as evidenced by its negative PE ratio of -9.99 and an EV to EBITDA ratio of -27.99, which are significantly worse than its peers. The Price to Book Value stands at 2.77, suggesting that the market is pricing the stock at a premium compared to its book value.<BR><BR>In comparison to peers, Bajaj Finance has a PE ratio of 34.9, while Life Insurance boasts a much more attractive EV to EBITDA of 8.92. This stark contrast highlights Salem Erode Investment's unfavorable position within the industry. Furthermore, the company's recent stock performance has been disappointing, with a year-to-date return of -21.69%, compared to a positive 9.12% return for the Sensex, reinforcing the notion that the stock is currently overvalued.

How has been the historical performance of Salem Erode Inv.?

Salem Erode Inv. has experienced declining financial performance, with net sales decreasing from 4.09 Cr in March 2024 to 3.85 Cr in March 2025, and significant operating losses worsening to -3.38 Cr in March 2025. Total expenditures rose sharply, contributing to a profit after tax of -4.72 Cr in March 2025.

Answer:<BR>The historical performance of Salem Erode Inv. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.<BR><BR>Breakdown:<BR>Salem Erode Inv. reported net sales of 3.85 Cr in March 2025, a decrease from 4.09 Cr in March 2024 and an increase from 4.00 Cr in March 2023. The total operating income mirrored this trend, remaining at 3.85 Cr in March 2025, down from 4.09 Cr in March 2024. The company has seen a substantial rise in total expenditure, which reached 7.28 Cr in March 2025, compared to 5.04 Cr in March 2024 and 3.70 Cr in March 2023. This increase in expenses has led to a significant operating loss, with an operating profit (PBDIT) of -3.38 Cr in March 2025, worsening from -0.90 Cr in March 2024. The profit before tax also declined sharply to -4.95 Cr in March 2025 from -1.77 Cr in March 2024, while profit after tax was -4.72 Cr in March 2025, down from -1.82 Cr in March 2024. The earnings per share (EPS) reflected this downturn, showing -4.1 in March 2025 compared to -1.58 in March 2024. Overall, the financial metrics indicate a deteriorating performance, particularly in the last two fiscal years.

Why is Salem Erode Inv. falling/rising?

As of N/A, Salem Erode Investments Ltd's stock price is declining at 42.39, down 0.26%, with a significant drop of 24.99% over the past week and a year-to-date decline of 19.99%, underperforming compared to the Sensex's 4.25% gain. The stock's short-term performance is notably worse than the benchmark, indicating ongoing struggles in the market.

As of N/A, Salem Erode Investments Ltd is experiencing a decline in its stock price, currently at 42.39, with a change of -0.11, representing a decrease of 0.26%. Unfortunately, the "Today's Price Summary" data is not available, which limits the ability to provide specific insights into today's trading activity. However, examining the returns from the "Stock vs Benchmark Returns," the stock has seen a significant drop of 24.99% over the past week and a year-to-date decline of 19.99%. This underperformance is notable compared to the Sensex, which has gained 4.25% year-to-date. There is no information available regarding positive or negative factors that could have influenced this recent movement.<BR><BR>In the broader market context, the stock's short-term performance is considerably worse than that of the benchmark, as indicated by the 1-week return of -24.99% compared to the Sensex's slight decline of only 0.36%. Over the past month, the stock has also underperformed, with a return of -4.72% against the Sensex's -1.56%. This trend suggests that while the overall market has faced minor setbacks, Salem Erode Investments Ltd has struggled significantly, contributing to its current downward price movement.

Who are the top shareholders of the Salem Erode Inv.?

The top shareholder of Salem Erode Inv. is Icl Fincop Limited, owning 75.0% of the shares, while individual investors hold 14.56%. There are no pledged promoter holdings or investments from mutual funds or foreign institutional investors.

The top shareholder of Salem Erode Inv. is Icl Fincop Limited, which holds a significant 75.0% of the company's shares. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Individual investors collectively hold 14.56% of the shares.

What is the technical trend for Salem Erode Inv.?

As of June 6, 2025, Salem Erode Inv. is in a neutral sideways trend, with mixed indicators showing mildly bullish weekly MACD and KST, but mildly bearish monthly MACD and daily moving averages, leading to a lack of strong directional signals.

As of 6 June 2025, the technical trend for Salem Erode Inv. has changed from mildly bearish to sideways. The current stance is neutral with a mix of indicators showing varying strengths. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating conflicting signals. The Bollinger Bands are bullish on the weekly chart but mildly bearish on the monthly, further contributing to the sideways trend. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST shows a mildly bullish trend on the weekly and bullish on the monthly, which could provide some support. Overall, the lack of strong directional signals in the RSI and Dow Theory reinforces the neutral stance.

Has Salem Erode Inv. declared dividend?

No Dividend History Available